Mineralys Therapeutics, Inc. (MLYS) stock
MLYSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.48−0.05 (-0.34%)
Close on Nov 17, 2026Market cap $1.28BP/E –Yield –
Mineralys Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Mineralys Therapeutics's price to book ratio was 2.6× on Nov 11, 2026, against 5.9× a year earlier. Over the last 4 years it ranged from 1.0× to 8.6×, with a median of 2.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.6× | −2.4 |
| 2025 | Dec 31, 2025 | 5.0× | +2.4 |
| 2024 | Dec 31, 2024 | 2.6× | +1.2 |
| 2023 | Dec 29, 2023 | 1.3× | – |
See a number that looks wrong?